发明名称
摘要 PROBLEM TO BE SOLVED: To develop a compound which is well absorbed orally, exhibits durability of good blood level and has potent calpain inhibitory activity. SOLUTION: The compound represented by general formula (I) (wherein R<SP>1</SP>is a lower alkyl substituted by a lower alkoxy or a heterocyclic group, or a heterocyclic group; R<SP>2</SP>is a lower alkyl optionally substituted by a phenyl; and R<SP>3</SP>is a lower alkyl optionally substituted by a halogen, a lower alkoxy or a phenyl, or a fused polycyclic hydrocarbon group), and having a calpain inhibitory activity. COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP4758641(B2) 申请公布日期 2011.08.31
申请号 JP20040354908 申请日期 2004.12.08
申请人 发明人
分类号 C07C271/12;A61K31/27;A61K31/341;A61K31/351;A61K31/44;A61K31/4402;A61P7/02;A61P9/10;A61P19/02;A61P19/10;A61P21/04;A61P25/00;A61P25/28;A61P27/02;A61P27/06;A61P27/12;A61P29/00;A61P35/00;A61P37/02;A61P43/00;C07C271/14;C07C271/16;C07C271/24;C07D213/30;C07D307/20;C07D309/12 主分类号 C07C271/12
代理机构 代理人
主权项
地址